Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Development (Cambridge, England)|January 26, 2026
Reciprocal inhibition of Wnt signaling pathways pattern the interconnection of epithelial tubules in the regenerating zebrafish kidneyCaramai N Kamei, William G B Sampson, Carolin Albertz, et al.
Bioorganic & Medicinal Chemistry Letters|September 6, 2016
Design and optimization of (3-aryl-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-ones as potent PLK4 inhibitors with oral antitumor efficacySze-Wan Li, Yong Liu, Peter B Sampson, et al.
Brain : a Journal of Neurology|May 5, 2023
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1Curtis A Nutter, Benjamin M Kidd, Helmut A Carter, et al.
Military Medicine|July 13, 2023
Beyond Trauma: High-Volume Critical Care Medicine in a Military Medical Center-Based Military-Civilian PartnershipJeremy P Kilburn, Stephanie M Streit, W Patrick Luan, et al.
Journal of Medicinal Chemistry|February 28, 2015
The discovery of Polo-like kinase 4 inhibitors: identification of (1R,2S).2-(3-((E).4-(((cis).2,6-dimethylmorpholino)methyl)styryl). 1H.indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one (CFI-400945) as a potent, orally active antitumor agentPeter B Sampson, Yong Liu, Bryan Forrest, et al.
Journal of Medicinal Chemistry|May 29, 2014
The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agentsPeter B Sampson, Yong Liu, Narendra Kumar Patel, et al.
Annals of Clinical and Translational Neurology|February 4, 2024
Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathySandra Donkervoort, Payam Mohassel, Melanie O'Leary, et al.
Human Mutation|October 6, 2011
Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD geneKevin M Flanigan, Diane M Dunn, Andrew von Niederhausern, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer AgentYong Liu, Radoslaw Laufer, Narendra Kumar Patel, et al.
American Journal of Human Genetics|March 21, 2017
Loss-of-Function Mutations in LGI4, a Secreted Ligand Involved in Schwann Cell Myelination, Are Responsible for Arthrogryposis Multiplex CongenitaShifeng Xue, Jérôme Maluenda, Florent Marguet, et al.
Pageof 17